Last reviewed · How we verify
NCT04343391
Brief Psychotherapies for Emotional Disorders in Primary and Secondary Care
NA trial testing Brief transdiagnostic cognitive-behavioral therapy in Emotional Disorder in 150 participants. Completed in 15 October 2020.
15 October 2020
Quick facts
| Lead sponsor | Universidad de Córdoba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 15 January 2020 |
| Primary completion | 15 October 2020 |
| Estimated completion | 15 October 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Brief transdiagnostic cognitive-behavioral therapy
- Pharmacological treatment — full drug profile →
Conditions studied
- Emotional Disorder — all drugs for Emotional Disorder →
Sponsor
Universidad de Córdoba
Who can join
Adults 18 to 65, any sex, with Emotional Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present work aims to develop a randomized clinical trial with a sample of 150 patients diagnosed with at least one of the following emotional disorder: somatoform disorder, panic disorder, generalized anxiety disorder and depression disorder. Participants are tested by several self-reports related to the emocional disorders mentioned in a repeated measures design, pre and post treatment. The investigators think this study will demonstrate that brief psychological treatments should be prioritized over pharmacological treatment for such pathologies in the Primary or Secondary Care context to improve the patient´s quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04343391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emotional Disorder
Currently open trials in the same condition.
- NCT07325565 — Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer · recruiting
- NCT06928480 — Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Peop · NA · recruiting
Other Universidad de Córdoba trials
Trials by the same sponsor.
- NCT06958094 — Effectiveness of Gamified Mobile Health Apps for Airway Clearance Therapy in Children and Adolescents With Cystic Fibros · NA · not yet recruiting
- NCT06409962 — A New Technological Intervention to Address Childhood Obesity: · NA · recruiting
- NCT06196866 — Effectiveness of Exergaming in Adittion to Conventional Treatment for Physical Therapy in People with Multiple Sclerosis · NA · active not recruiting
- NCT05289258 — Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments · NA · recruiting
- NCT04366401 — Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04343391 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Córdoba
- Last refreshed: 4 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04343391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing